Opdivo
(Nivolumab)
(100 mg)
(one)
(Ampoule)
Opdivo (nivolumab) 100mg BMS US
Article:
Indications
Opdivo (nivolumab) - a drug for the treatment of patients with unresectable or metastatic melanoma in the presence of melanoma, which is accompanied by a BRAF gene mutation, if the use of BRAF inhibitors does not bring the expected effect; for the treatment of patients with metastatic squamous progressive lung cancer. Treatment with nivolumab is carried out under the supervision of the attending physician, who determines its dosage and frequency of administration, based on current standard treatment protocols. If severe side effects occur, the doctor may stop the drug or adjust the dosage.820/car
Analogues: There are no known analogues.
Spelling errors: apdivo, apdeva, apdivo, opdeva, opdiva,
-
Commercial name:Opdivo
-
Сhemical name:Nivolumab
-
Dosage:100 mg
-
Quantity:one
-
Release form:Ampoule
-
Производитель:BRISTOL MYERS
No reviews yet